Calendar

May
11
Tue
2021
Cancer Early Detection Seminar Series - Michael Berger, Ph.D. @ Zoom - See Description for Zoom Link
Cancer Early Detection Seminar Series – Michael Berger, Ph.D.
May 11 @ 11:00 am – 12:00 pm Zoom - See Description for Zoom Link
Cancer Early Detection Seminar Series - Michael Berger, Ph.D. @ Zoom - See Description for Zoom Link

CEDSS: “Building a Scalable Clinical Genomics Program: How tumor, normal, and plasma DNA sequencing are informing cancer care, cancer risk, and cancer detection”

 

Michael Berger, Ph.D.

Elizabeth and Felix Rohatyn Chair & Associate Director of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology
Memorial Sloan Kettering Cancer Center

 

Zoom Details
Meeting URL: https://stanford.zoom.us/s/92559505314
Dial: US: +1 650 724 9799  or +1 833 302 1536 (Toll Free)
Meeting ID: 925 5950 5314
Passcode: 418727

11:00am – 12:00pm Seminar & Discussion
RSVP Here

 

ABSTRACT
Tumor molecular profiling is a fundamental component of precision oncology, enabling the identification of oncogenomic mutations that can be targeted therapeutically. To accelerate enrollment to clinical trials of molecularly targeted agents and guide treatment selection, we have established a center-wide, prospective clinical sequencing program at Memorial Sloan Kettering Cancer Center using a custom, paired tumor-blood normal sequencing assay (MSK-IMPACT), which we have used to profile more than 50,000 patients with solid tumors. Yet beyond just the characterization of tumor-specific alterations, the inclusion of blood DNA has readily enabled the identification of germline risk alleles and somatic mutations associated with clonal hematopoiesis. To complement this approach, we have also implemented a ‘liquid biopsy’ cfDNA panel (MSK-ACCESS) for cancer detection, surveillance, and treatment selection and monitoring. In my talk, I will describe the prevalence of somatic and germline genomic alterations in a real-world population, the clinical benefits of cfDNA assessment, and how clonal hematopoiesis can inform cancer risk and confound liquid biopsy approaches to cancer detection.

 

ABOUT
Michael Berger, PhD, holds the Elizabeth and Felix Rohatyn Chair and is Associate Director of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology at Memorial Sloan Kettering Cancer Center, a multidisciplinary initiative to promote precision oncology through genomic analysis to guide the diagnosis and treatment of cancer patients. He is also an Associate Attending Geneticist in the Department of Pathology with expertise in cancer genomics, computational biology, and high-throughput DNA sequencing technology. His laboratory is developing experimental and computational methods to characterize the genetic makeup of individual cancers and identify genomic biomarkers of drug response and resistance. As Scientific Director of Clinical NGS in the Molecular Diagnostics Service, he oversees the development and bioinformatics associated with clinical sequencing assays, and he helped lead the development and implementation of MSK-IMPACT, a comprehensive FDA-authorized tumor sequencing panel that been used to profile more than 60,000 tumors from advanced cancer patients at MSK. The resulting data have enabled the characterization of somatic and germline biomarkers across many cancer types and the identification of mutations associated with clonal hematopoiesis. Dr. Berger also led the development of a clinically validated plasma cell-free DNA assay, MSK-ACCESS, which his laboratory is using to explore tumor evolution, acquired drug resistance, and occult metastatic disease. He received his Bachelor’s Degree in Physics from Princeton University and his Ph.D. in Biophysics from Harvard University.

 

Hosted by: Utkan Demirci, Ph.D.
Spon
sored by: The Canary Center & the Department of Radiology 
Stanford University – School of Medicine

May
12
Wed
2021
MIPS Special Seminar - Jubilant Biosys @ Zoom - See Description for Zoom Link
MIPS Special Seminar – Jubilant Biosys
May 12 @ 9:00 am – 10:00 am Zoom - See Description for Zoom Link
MIPS Special Seminar - Jubilant Biosys @ Zoom - See Description for Zoom Link

MIPS Special Seminar: Jubilant Biosys: Drug discovery and contract research services, from target discovery to candidate selection

 

Thomas Haywood, PhD
Head of International Radiochemistry Collaborations
Stanford University

 

Saurabh Kapure, MBA
Vice President, Business Development (USA & APAC)
Jubilant Biosys Limited

 

Jay Sheth, MBA
Manager Business Development, Drug Discovery Services, and CDMO
Jubilant Biosys Limited

 

LOCATION: Zoom
Meeting URL: https://stanford.zoom.us/j/98108346345
Dial: +1 650 724 9799 or +1 833 302 1536
Meeting ID: 981 0834 6345
Passcode: 397741

SCHEDULE
9:00-9:15  AM, PT Thomas Haywood – Stanford Radiology projects
9:15-9:30 AM, PT – Saurabh Kapure – Introduction to Jubilant Biosys, Scale-up and GMP manufacturing
9:30-9:40 AM, PT Jay Sheth – How Jubilant Biosys works with academic partners: examples and case-studies
9:40-10:00 AM, PT – Moderated by Jason Thanh Lee  – Discussion

 

ABOUT
Jubilant Biosys, an integrated contract research organization in India with business offices in Asia and North America, is a leading collaborator for biotechnology and pharmaceutical companies, with in-depth expertise in discovery informatics, medicinal chemistry, structural biology, and in vitro pharmacology services. Jubilant Biosys provides comprehensive drug discovery services and contract research services, from target discovery to candidate selection and with flexible business models (FFS, FTE and risk shared). This seminar will showcase case studies from recent Stanford projects and a discussion of future opportunities.

 

Sponsored by: Molecular Imaging Program at Stanford, Department of Radiology

May
21
Fri
2021
Radiology-Wide Research Meeting
Radiology-Wide Research Meeting
May 21 @ 12:00 pm – 1:00 pm
Radiology-Wide Research Meeting

Radiology Department-Wide Research Meeting

• Research Announcements
• Koen Nieman, M.D., PhD – Coronary Artery Disease by Computed Tomography
• Martin Willemink, M.D., PhD – Translating Emerging Cardiovascular CT Techniques into the Clinical Setting

Location: Zoom – Details can be found here: https://radresearch.stanford.edu
Meetings will be the 3rd Friday of each month.

 

Hosted by: Daniel Ennis, PhD
Sponsored by: the the Department of Radiology

May
27
Thu
2021
MIPS Seminar - Geoffrey Sonn, MD @ Zoom - See Description for Zoom Link
MIPS Seminar – Geoffrey Sonn, MD
May 27 @ 12:00 pm – 12:45 pm Zoom - See Description for Zoom Link
MIPS Seminar - Geoffrey Sonn, MD @ Zoom - See Description for Zoom Link

MIPS Seminar Series: Image-guided focal therapy for prostate cancer

Geoffrey Sonn, MD
Assistant Professor of Urology and, by courtesy, of Radiology (Molecular Imaging Program at Stanford)
Stanford University Medical Center

 

Location: Zoom
Webinar URL: https://stanford.zoom.us/s/96126703618
Dial: +1 650 724 9799 or +1 833 302 1536
Webinar ID: 961 2670 3618
Passcode: 186059

12:00pm – 12:45pm Seminar & Discussion
RSVP Here

 

ABSTRACT

In recent years, prostate cancer treatment has increasingly focused on selecting patients who are most likely to benefit and reducing harms from treatment. This has been seen both in adoption of active surveillance for men with low-risk prostate cancer and emergence of image-guided focal ablative therapy. While focal therapy causes fewer sexual and urinary side effects than conventional prostate cancer treatments, many questions remain about proper patient selection, treatment planning, and follow up care.

 

Improvements in prostate MRI performance and interpretation have paved the way for adoption of focal therapy. However, clinical challenges remain in prostate cancer imaging. This talk will describe prostate cancer focal therapy, discuss patient selection, and highlight the research efforts of my group to improve MRI interpretation to guide biopsy and improve focal therapy performance.

 

ABOUT
Geoffrey Sonn, MD is a urologic oncologist who specializes in treating patients with prostate and kidney cancer. He has a particular interest in cancer imaging, MRI-Ultrasound fusion targeted prostate biopsy, prostate cancer focal therapy, and robotic surgery for prostate and kidney cancer. He is the principal investigator of the first clinical trial in Northern California to use MRI-guided focused ultrasound to treat prostate cancer. The goal of this trial is to treat prostate cancer with fewer side effects than surgery or radiation.

Dr. Sonn was born in Washington State and lived there until leaving for college at Georgetown. After graduating magna cum laude at Georgetown he returned to the West Coast for medical school at UCLA. Following medical school, Dr. Sonn completed a 6-year urology residency at Stanford where he developed particular interests in the clinical care of patients with urologic cancers and research in cancer imaging. Dr. Sonn completed a 2-year urologic oncology fellowship at UCLA. Since completing his fellowship, Dr. Sonn has been at Stanford as an assistant professor in urology. Dr. Sonn’s research is devoted to developing new cancer imaging techniques, applying artificial intelligence to find cancers on medical images, and applying new methods to treat prostate cancer with fewer side effects.

 

Hosted by: Katherine Ferrara, PhD
Sponsored by: Molecular Imaging Program at Stanford & the Department of Radiology

Jun
21
Mon
2021
International Conference on Functional Imaging and Modeling of the Heart @ Virtual Event
International Conference on Functional Imaging and Modeling of the Heart
Jun 21 – Jun 25 all-day Virtual Event
International Conference on Functional Imaging and Modeling of the Heart @ Virtual Event

Join us for the 11th biennial International Conference on Functional Imaging and Modeling of the Heart (FIMH). FIMH-2021 will celebrate 20 years of bringing together friends, colleagues, and collaborators to share and discuss the latest in cardiac and cardiovascular imaging, electrophysiology, computational modeling, and translational applications. The event will take place June 21-25, 2021 virtually, via Livestream, Zoom meeting workshops, and Spatial Chat networking.

 

Sponsored by: Functional Imaging and Modeling of the Heart Conference

Jun
30
Wed
2021
Molecular Imaging in Neuroscience - MIPS Mini-Retreat @ Virtual Event
Molecular Imaging in Neuroscience – MIPS Mini-Retreat
Jun 30 @ 8:00 am – 10:00 am Virtual Event
Molecular Imaging in Neuroscience - MIPS Mini-Retreat @ Virtual Event

Molecular Imaging in Neuroscience – MIPS Mini-Retreat

Hosted by: Dr. Michelle L. James, PhD

Sponsored by: Department of Radiology, Molecular Imaging Program at Stanford

 

The MIPS Mini-retreat series brings together members of the MIPS and greater School of Medicine community to discuss current opportunities for research and collaborations. During each mini-retreat we will discuss a different topic and we invite all those interested to attend. The mini-retreats are roughly two hours in length with ample time for discussion throughout. We hope you can join us and spark new collaborations!

 

Zoom Webinar Information
Webinar URL: https://stanford.zoom.us/j/92903233643
Dial: US: +1 650 724 9799  or +1 833 302 1536 (Toll Free)
Webinar ID: 929 0323 3643
Passcode: 146018

 

Tentative Agenda (all times are in PST)
8:00-8:05 AM – Opening Remarks – Michelle James, PhD
8:05-8:55 AM – Overview and Imaging-based Collaboration: Department of Neurology, Neurosurgery, Pathology, Psychiatry, and Nuclear Medicine (Frank M. Longo, MD, PhD, Michael Lim, MD, Thomas Montine, MD, PhD, Victor G. Carrión, MD, and Guido Davidzon, MD)
8:55-9:20 AM – Faculty Introductions: All interested MIPS faculty on the call give a 2-minute introduction including their interest in collaborating with Neurology, Pathology, Neurosurgery, and/or Psychiatry and Behavioral Sciences departments.
9:20-9:40 AM – Recent center proposals and possible mechanisms: UDALL Collaboration – Michelle James, PhD and Kathleen Poston, MD, MS
9:40-10:00 AM – Discussion – Moderated by: Michelle James, PhD and Katherine Ferrara, PhD

Jul
16
Fri
2021
Radiology-Wide Research Conference @ Zoom – Details can be found here: https://radresearch.stanford.edu
Radiology-Wide Research Conference
Jul 16 @ 12:00 pm – 1:00 pm Zoom – Details can be found here: https://radresearch.stanford.edu
Radiology-Wide Research Conference @ Zoom – Details can be found here: https://radresearch.stanford.edu

Radiology Department-Wide Research Meeting

• Research Announcements
• Mirabela Rusu, PhD – Learning MRI Signatures of Aggressive Prostate Cancer: Bridging the Gap between Digital Pathologists and Digital Radiologists
• Akshay Chaudhari, PhD – Data-Efficient Machine Learning for Medical Imaging

Location: Zoom – Details can be found here: https://radresearch.stanford.edu
Meetings will be the 3rd Friday of each month.

 

Hosted by: Kawin Setsompop, PhD
Sponsored by: the the Department of Radiology

Jul
19
Mon
2021
Gambhir Symposium @ Virtual Event
Gambhir Symposium
Jul 19 @ 8:30 am – 4:00 pm Virtual Event
Gambhir Symposium @ Virtual Event

Dr. Sanjiv Sam Gambhir was a visionary who had a profound impact on the world of science and humanity. As a leader and pioneer in the fields of molecular imaging, early detection of cancer, and precision health, his enduring legacy can be seen in the research and innovations continuing in these fields today.

The Gambhir Symposium aims to celebrate Dr. Gambhir’s illustrious career and continue down the paths he forged by highlighting the work still ongoing in the fields he helped to cultivate. Join us to hear researchers and collaborators share current thoughts and future outlooks on topics developed with Sam.

We hope you can join us for the 2021 Virtual Gambhir Symposium.

The event is fully virtual and the livestream link will be posted on the website closer to the event.

 

Sponsored by: Department of Radiology at Stanford 

Aug
3
Tue
2021
2021 AIMI Symposium + BOLD-AIR Summit @ Virtual Livestream
2021 AIMI Symposium + BOLD-AIR Summit
Aug 3 @ 8:00 am – Aug 4 @ 3:00 pm Virtual Livestream
2021 AIMI Symposium + BOLD-AIR Summit @ Virtual Livestream

Stanford AIMI Director Curt Langlotz and Co-Directors Matt Lungren and Nigam Shah invite you to join us on August 3 for the 2021 Stanford Center for Artificial Intelligence in Medicine and Imaging (AIMI) Symposium. The virtual symposium will focus on the latest, best research on the role of AI in diagnostic excellence across medicine, current areas of impact, fairness and societal impact, and translation and clinical implementation. The program includes talks, interactive panel discussions, and breakout sessions. Registration is free and open to all.

 

Also, the 2nd Annual BiOethics, the Law, and Data-sharing: AI in Radiology (BOLD-AIR) Summit will be held on August 4, in conjunction with the AIMI Symposium. The summit will convene a broad range of speakers in bioethics, law, regulation, industry groups, and patient safety and data privacy, to address the latest ethical, regulatory, and legal challenges regarding AI in radiology.

 

REGISTER HERE

Sep
10
Fri
2021
CME Grand Rounds Sanjiv Sam Gambhir Lectureship - Simon Cherry, PhD @ LKSC 101/102 & Zoom - See Description for Zoom Link
CME Grand Rounds Sanjiv Sam Gambhir Lectureship – Simon Cherry, PhD
Sep 10 @ 12:00 pm – 1:00 pm LKSC 101/102 & Zoom - See Description for Zoom Link
CME Grand Rounds Sanjiv Sam Gambhir Lectureship - Simon Cherry, PhD @ LKSC 101/102 & Zoom - See Description for Zoom Link

CME Grand Rounds Sanjiv Sam Gambhir Lectureship – “Imaging at the Speed of Light:  Innovations in Positron Emission Tomography”

 

Simon R. Cherry, PhD
Professor
Biomedical Engineering & Radiology
UC Davis

 

Join from PC, Mac, Linux, iOS or Android: https://stanford.zoom.us/j/600003703?pwd=RjcwS2MvOG1qVkxyL3U0RmNtUDVWdz09
Meeting ID: 600 003 703
Password: 566048
Or iPhone one-tap (US Toll): +18333021536,,600003703# or +16507249799,,600003703#
Or Telephone:
Dial: +1 650 724 9799 (US, Canada, Caribbean Toll) or +1 833 302 1536 (US, Canada, Caribbean Toll Free)
International numbers available: https://stanford.zoom.us/u/acuqphnvqT

 

ABSTRACT

Positron emission tomography (PET) allows for sensitive and quantitative measurement of physiology, metabolism and molecular targets noninvasively in the human body.  However, typical clinical PET scanners capture less than 1% of the available signal produced in the body.  PET scanners also are not currently capable of precisely determining the location at which a particular decay occurs. These limitations present opportunities for further innovation that ultimately will impact molecular imaging research and diagnostic imaging with PET.  This presentation focuses on 1) total-body PET imaging which greatly improves signal collection, allowing radiotracer kinetics to be assessed across the entire human body for the first time, and 2) the development of detector technologies that have a timing precision of ~ 30 picoseconds, enabling direct localization of radiotracer decays without tomographic reconstruction.

 

BIO

Simon R. Cherry, Ph.D.  received his B.Sc.(Hons) in Physics with Astronomy from University College London in 1986 and a Ph.D. in Medical Physics from the Institute of Cancer Research, University of London in 1989.  After a postdoctoral fellowship at UCLA, he joined the faculty in the Department of Molecular and Medical Pharmacology, also at UCLA, in 1993. In 2001, Dr. Cherry joined UC Davis and established the Center for Molecular and Genomic Imaging, which he directed from 2004-2016. Currently Dr. Cherry is Distinguished Professor in the Departments of Biomedical Engineering and Radiology at UC Davis.

Dr. Cherry’s research interests center around biomedical imaging and in particular the development and application of in vivo molecular imaging systems.  His major accomplishments have been in developing systems for positron emission tomography (PET), in particular the invention of the microPET technology that was subsequently widely adopted in academia and industry and as co-leader of the EXPLORER consortium which has developed the world’s first total-body PET scanner.  He also has contributed to detector technology innovations for PET, conducted early biomedical studies using Cerenkov luminescence, and developed the first proof-of-concept hybrid PET/MRI (magnetic resonance imaging) systems.

Dr. Cherry is a founding member of the Society of Molecular Imaging and an elected fellow of six professional societies, including the Institute for Electronic and Electrical Engineers (IEEE) and the Biomedical Engineering Society (BMES). He served as Editor-in-Chief of the journal Physics in Medicine and Biology from 2011-2020. Dr. Cherry received the Academy of Molecular Imaging Distinguished Basic Scientist Award (2007), the Society for Molecular Imaging Achievement Award (2011) and the IEEE Marie Sklodowska-Curie Award (2016).   In 2016, he was elected as a member of the National Academy of Engineering and in 2017 he was elected to the National Academy of Inventors.  Dr. Cherry is the author of more than 240 peer-reviewed journal articles, review articles and book chapters in the field of biomedical imaging. He is also lead author of the widely-used textbook “Physics in Nuclear Medicine”.